Patent · US Active

Crystalline form of s-apomorphine

US11459301B2 · kind B2 · utility

0Cited by
0References
18Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMay 13, 2019
Grant dateOct 4, 2022
Priority date
Expiry dateAug 19, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/13
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention is directed to a novel crystalline S-apomorphine hydrochloride hydrate salt.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.